The Managing Patients with Limited Treatment Options - EU Series was comprised of five editions in regional languages with local experts, covering the latest treatment options tailored to regional needs.
Meeting category
Date(s)
1 Apr 2022 - 30 Jun 2022
Meeting type
Virtual Meeting
Organizer
Managing HIV Patients with Limited Treatment Options - EU Series 2022
Related Enduring Materials
Enduring Materials
Previous Editions
German Edition - 28 April 2022 - 18.30
18.30 CEST
Begrüßung
18:35 CEST
Betreuung von HIV-Patienten mit eingeschränkten Therapieoptionen
18:55 CEST
Diskussionsrunde
Klinische Fallstudien - Moderierte Diskussionsrunde
19:05 CEST
Klinischer Fall 1
Kathrin van Bremen, MD
Universitätsklinikum Bonn, Germany
19:20 CEST
Klinischer Fall 2
19:35 CEST
Klinischer Fall 3
19:50 CEST
Zusammenfassung / Lernerfolgskontrolle
French Edition - 3 May 2022 - 18:30
18:30 CEST
Mots de bienvenue
18:35 CEST
Prise en charge des PVVIH ayant des options de traitement limitées
18:55 CEST
Débat
19:05 CEST
Débat sur les cas cliniques
19:05 CEST
Cas clinique 1
19:20 CEST
Cas clinique 2
19:50 CEST
Mot de clôture/ Leçons apprises
Italian Edition - 19 May 2022 - 17:30
17:30 CEST
Introduzione ai Lavori
17:35 CEST
La Gestione di Percorsi Terapeutici Per Pazienti Con Opzioni Terapeutiche Limitate
17:55 CEST
Discussione
18:05 CEST
Discussione su Casi Clinici
18:05
Caso Clinico 1
Micol Ferrara
Ospedale San Raffaele S.r.l., Italy
18:20
Caso Clinico 2
Marianna Menozzi
Azienda Ospedaliero Universitaria Policlinico Modena, Italy
18:35
Caso Clinico 3
Vincenzo Spagnuolo
Vita-Salute San Raffaele University, Italy
18:50 CEST
Discussione e Commenti Finali
Spanish Edition - 26 May 2022 - 17:00
Josep Llibre, MD, PhD
Josep Llibre, MD, PhD
Josep Llibre, MD, PhD
17:00 CEST
Palabras de Apertura
17:05 CEST
Manejo de PLWHIV en Pacientes con Tratamientos Limitados
Fundació Lluita contra la Sida; Hospital Universitari Germans Trias i Pujol, Spain
17:25 CEST
Debate
Fundació Lluita contra la Sida; Hospital Universitari Germans Trias i Pujol, Spain
17:35 CEST
Debate Sobre Casos Clínicos
Fundació Lluita contra la Sida; Hospital Universitari Germans Trias i Pujol, Spain
17:35
Casos Clínicos 1
Lucia Bailon
Enfermedades Infecciosas, Hospital Universitari Germans Trias, Badalona, Spain
17:50
Casos Clínicos 2
Rocío Montejano
Enfermedades Infecciosas, Hospital Universitario La Paz, Madrid, Spain
18:05
Casos Clínicos 3
Laura Viñuela
Enfermedades Infecciosas, Hospital Universitario Virgen de las Nieves, Granada, Spain
18:20 CEST
Conclusiones y Aclaraciones I Lecciones Aprendidas
English Edition - 29 June 2022 - 17.30
17.30 BST
Welcome Words
17:35 BST
Management of PLWHIV with Limited Treatment Options
17:55 BST
Discussion
18:35
Clinical Case Discussions
18:05 BST
Clinical Case 1
18:20 BST
Clinical Case 2
18:50
Closing Remarks / Lessons Learned
General
Image
Welcome
This program addressed the available tools to identify these patients, explore resistance considerations in treatment decisions, and discuss how to tackle polypharmacy, drug-drug interactions, co-morbidities, and more!
Attendees gained insights into new treatment options and how best to integrate them into optimal antiretroviral regimens.
This webinar series was comprised of five editions, each in a different language, all featuring both regional and international experts.
We invite you to view the enduring materials from the following editions:
- German
- French
- Italian
- Spanish
- English
Program Director
What's New
- Make sure that you are registered for our newsletter to receive the latest information on the second series of this program.
General Information
COVID-19 Update
Responding to the changing COVID-19 situation, the Managing HIV Patients with Limited Treatment Options - EU Series 2022 was held as a virtual meeting.
We are available to answer any questions or concerns that you may have about your participation at the Managing HIV Patients with Limited Treatment Options - EU Series 2022.
For more information, please contact Paula Janiak at paula.janiak@amededu.com.
We are available to answer any questions or concerns that you may have about your participation at the Managing HIV Patients with Limited Treatment Options - EU Series 2022.
For more information, please contact Paula Janiak at paula.janiak@amededu.com.
Who Should Attend?
This activity is intended for all HIV healthcare professionals. Specifically:
- HIV physicians experienced in treating HIV patients with limited treatment options in need of the latest information on new treatment options.
- HIV physicians inexperienced in treating patients with limited treatment options who need more comprehensive education on identifying and managing these patients with emphasis on new drugs;
- Clinical pharmacologists involved in the concomitant medication management and dose adjusting for co-morbidities of patients with limited treatment options;
- Other EU healthcare professionals (e.g. nurse practitioners) involved in the medical care of patients with limited treatment options.
- HIV physicians experienced in treating HIV patients with limited treatment options in need of the latest information on new treatment options.
- HIV physicians inexperienced in treating patients with limited treatment options who need more comprehensive education on identifying and managing these patients with emphasis on new drugs;
- Clinical pharmacologists involved in the concomitant medication management and dose adjusting for co-morbidities of patients with limited treatment options;
- Other EU healthcare professionals (e.g. nurse practitioners) involved in the medical care of patients with limited treatment options.
Learning Objectives
At the completion of this program participants were able to:
- Define patients with limited treatment options and tools to identify them;
- Understand key challenges and general considerations in the treatment of those patients;
- Understand the implications of drug resistance and co-morbidities in creating optimal treatment regimens;
- Increase knowledge of new treatment options available for these patients;
- Describe how best to integrate new drugs into optimal combination regimens.
- Define patients with limited treatment options and tools to identify them;
- Understand key challenges and general considerations in the treatment of those patients;
- Understand the implications of drug resistance and co-morbidities in creating optimal treatment regimens;
- Increase knowledge of new treatment options available for these patients;
- Describe how best to integrate new drugs into optimal combination regimens.
Practical Information
Certificate of Attendance
A certificate of attendance will be sent to participants who successfully complete the program and post-meeting survey.
Language
This series is provided in several editions, including the following languages:
- German
- French
- Italian
- Spanish
- English
- German
- French
- Italian
- Spanish
- English
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Chairs
Program Director
Support
The Managing HIV Patients With Limited Treatment Options series is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Paula at Paula.Janiak@amededu.com or call +31 30 230 7140.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgement during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgement on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level.
Media
Invitation to Join the German Edition
Join local chair of the German language edition, Jürgen Rockstroh, on 28 April.
Register today: https://virology.eventsair.com/mhplto-eu-2022/reg-2
Invitation from José Arribas
José Arribas, local chair of the Spanish Edition, invites you to join the webinar on Thursday 26 May 2022.
Register today: https://virology.eventsair.com/mhplto-eu-2022/reg-sp
Invitation from Anton Pozniak
Anton Pozniak, local chair of the English Edition, invites you to join the webinar on Wednesday 29 June 2022.
Register today: https://virology.eventsair.com/mhplto-eu-2022/registration-english
Language
Related Programs
